DocDollars

Fresenius USA Marketing, Inc.

MA · United States · Reporting entity ID 100000000257

Total reported 2019–2025
$9.01M
#525 of 2,960 reporting companies — 0% of all reported industry payments
$4.84M in general payments across 58,032 records, plus $4.17M in research funding across 141 records.

How it breaks down

General payments $4,838,947
Research funding $4,173,369

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Fresenius USA Marketing, Inc. reported $9.01M to US doctors and teaching hospitals from 2019 to 2025, ranking #525 of 2,960 reporting companies. 46% of that was research funding and 54% general payments such as consulting, speaking, food and travel. 58,032 general payment records and 141 research records were filed.

Common questions about Fresenius USA Marketing, Inc.

How much has Fresenius USA Marketing, Inc. paid US doctors?

Fresenius USA Marketing, Inc. reported $9,012,316 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $4,838,947 in general payments, $4,173,369 in research funding.

How does Fresenius USA Marketing, Inc. rank among drug and device companies?

It ranks #525 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Fresenius USA Marketing, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.